Protocol Quick-Reference PRECLINICAL ONLY: NNMT inhibition research compound Dosing Amount No established human dose (mouse: ~34 mg/kg/day SC) Frequency No established human frequency Duration No established human duration Administration Route Oral Schedule N/A (preclinical compound) Timing NO HUMAN DOSING DATA EXISTS
Researchers have reported that it is a complicated illness caused by genetics, environmental factors, vitamin deficiencies, and smoking, resulting in neuronal cell death, nerve demyelination, and neural dysfunction
Before beginning any treatment or supplement regimen, please consult your healthcare provider to ensure its appropriate and safe
Possible factors include: Autoimmune diseases Liver illness Severe infections A low platelet count, also known as thrombocytopenia, signifies that the body has fewer platelets than needed for optimal clotting
An adequate amount of vitamin B2, alongside vitamin B6 and folate, is beneficial in optimising cardiovascular health